ArticleHaematologica2026

Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease.

Fernando Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.